phrykt

Cencora, Inc. (COR): who owns it and who trades it

As of Nov 16, 2026, COR insiders reported 13 open-market sales worth $15.4M and 3 purchases worth $2.3M in the last 12 months, with 53% of the sale value made under pre-set 10b5-1 plans. The largest seller was Robert P. Mauch (CEO), with $7.3M. 6 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Cencora

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns COR

1,339 funds and institutions reported COR shares worth $52B at the end of Q2 2026, about 94% of the company. The largest holder is BlackRock, Inc. with 9.4%.

Funds and institutions (13F) 94%Everyone else 6%

10 largest owners, by share of the company

BlackRock, Inc.9.4%
Vanguard Capital Management LLC6.4%
Vanguard Portfolio Management LLC4.9%
State Street Corp4.8%
T. Rowe Price Investment Management, Inc.3.8%
T. Rowe Price Associates3.7%
JPMorgan Chase & Co3.1%
Geode Capital Management, LLC2.8%
Boston Partners2.5%
Wellington Management Group LLP2.3%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.18.21M9.36%$5.2B-9%
Vanguard Capital Management LLC12.38M6.36%$3.5B+1%
Vanguard Portfolio Management LLC9.61M4.94%$2.7B+0%
State Street Corp9.27M4.77%$2.6B+1%
T. Rowe Price Investment Management, Inc.7.41M3.81%$2.1B+18%
T. Rowe Price Associates7.13M3.67%$2B-3%
JPMorgan Chase & Co5.94M3.05%$1.7B–
Geode Capital Management, LLC5.45M2.80%$1.5B-2%
Boston Partners4.87M2.50%$1.4B+9%
Wellington Management Group LLP4.56M2.34%$1.3B+0%
FMR LLC (Fidelity)4.12M2.12%$1.2B-38%
Morgan Stanley4.09M2.10%$1.2B-10%
Bank of America Corp3.73M1.92%$1.1B-10%
Norges Bank2.47M1.27%$700M–
Goldman Sachs Group Inc2.27M1.17%$644M+3%
Amundi2.23M1.15%$631M+44%
Northern Trust Corp2.16M1.11%$611M-1%
Invesco Ltd.2.02M1.04%$572M-49%
Capital Research Global Investors1.98M1.02%$560M+1%
Carmignac Gestion1.75M0.90%$494M–

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, COR insiders reported $2.3M of open-market purchases and $15.4M of sales. 53% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$2.3M
3 trades, 2 people
Sales, 12 months
$15.4M
13 trades, 5 people
Sales under a 10b5-1 plan
53%
Share of sale value
Latest trade
Nov 2, 2026
Filed Nov 3, 2026

Purchases and sales by month

$4.9M$4.9MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 2, 2026Lazarus KrikorianVice presidentSale plan986$330.96$326KForm 4
Oct 1, 2026Lazarus KrikorianVice presidentSale plan986$303.18$299KForm 4
Sep 16, 2026Lon R GreenbergDirectorSale1,280$321.30$411KForm 4
Sep 1, 2026Lazarus KrikorianVice presidentSale plan985$325.97$321KForm 4
Aug 24, 2026Elizabeth S CampbellVice presidentSale11,300$324.12$3.7MForm 4
Jun 22, 2026Lauren M TylerDirectorPurchase550$270.23$149KForm 4
Jun 18, 2026Dermot Mark DurcanDirectorPurchase4,000$274.19$1.1MForm 4
May 28, 2026Dermot Mark DurcanDirectorPurchase4,000$266.26$1.1MForm 4
Feb 20, 2026Robert P. MauchCEOSale plan3,762$358.94$1.4MForm 4
Feb 18, 2026Robert P. MauchCEOSale plan1,333$359.46$479KForm 4
Jan 20, 2026Robert P. MauchCEOSale plan5,096$354.73$1.8MForm 4
Dec 19, 2025Silvana BattagliaVice presidentSale1,677$345.00$579KForm 4
Dec 19, 2025Elizabeth S CampbellVice presidentSale3,351$342.10$1.1MForm 4
Dec 18, 2025Robert P. MauchCEOSale plan5,096$343.45$1.8MForm 4
Dec 17, 2025Lazarus KrikorianVice presidentSale4,031$343.24$1.4MForm 4
Nov 18, 2025Robert P. MauchCEOSale plan5,096$366.64$1.9MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Robert P. MauchPresident & CEO, Director–$7.3MFeb 20, 2026
Elizabeth S CampbellExecutive Vice President–$4.8MAug 24, 2026
Lazarus KrikorianSVP & Chief Accounting Officer–$2.3MNov 2, 2026
Dermot Mark DurcanDirector$2.2M–Jun 18, 2026
Silvana BattagliaExecutive Vice President–$579KDec 19, 2025
Lon R GreenbergDirector–$411KSep 16, 2026
Lauren M TylerDirector$149K–Jun 22, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

COR short interest

Low short interest. 1.7% of COR shares are sold short: about 1 share in 60. Over the last 12 reports the number of shares short went down 40%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 3.16M COR shares were sold short, 1.7% of the shares outstanding, down 19.7% from the report before. At the average daily volume of 1.21M shares, buying them all back would take about 2.6 trading days (days to cover).

Shares short, % of all shares

1.65%May 15Oct 303.44%

Days to cover

2.6May 15Oct 305.2

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20263.16M1.65%-20%1.21M2.6
Oct 15, 20263.93M2.06%+0%1.15M3.4
Sep 30, 20263.92M2.05%-9%1.37M2.9
Sep 15, 20264.31M2.26%-5%1.26M3.4
Aug 31, 20264.53M2.37%-2%1.01M4.5
Aug 14, 20264.64M2.43%-10%1.94M2.4
Jul 31, 20265.17M2.71%-12%1.24M4.2
Jul 15, 20265.87M3.02%+7%1.50M3.9
Jun 30, 20265.50M2.83%-12%1.84M3.0
Jun 15, 20266.24M3.21%+13%1.32M4.7
May 29, 20265.53M2.84%+4%1.84M3.0
May 15, 20265.29M2.72%+2%2.90M1.8

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded COR

Since Nov 17, 2024, 4 members of Congress reported 4 purchases and 4 sales of COR. The latest was a sale by Jared Moskowitz on May 6, 2026, reported Jun 19, 2026.

Purchases 4Sales 4

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
May 6, 2026Jared Moskowitz (D-FL)Sale$1K–$15KChildJun 19, 2026Report
May 6, 2026Jared Moskowitz (D-FL)Sale$1K–$15KSelfJun 19, 2026Report
Mar 31, 2026Jared Moskowitz (D-FL)Purchase$1K–$15KSelfApr 30, 2026Report
Mar 27, 2026Alan Armstrong (R-OK)Purchase$1K–$15KSelfJul 21, 2026Report
Mar 23, 2026Jared Moskowitz (D-FL)Purchase$1K–$15KChildApr 30, 2026Report
Mar 23, 2026Jared Moskowitz (D-FL)Purchase$1K–$15KSelfApr 30, 2026Report
May 12, 2025Jefferson Shreve (R-IN)Sale$50K–$100KSelfJun 22, 2025Report
Mar 27, 2025Greg Landsman (D-OH)Sale$15K–$50KSpouseApr 8, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Cencora company events

Cencora filed 22 reports on Form 8-K in the last 12 months, 6 of them about an important change (leadership). The latest was on Nov 4, 2026.

  1. Nov 4, 2026AnnouncementShared information with investors. Filing
  2. Nov 4, 2026ResultsReleased financial results. Filing
  3. Oct 21, 2026ResultsReleased financial results. Filing
  4. Sep 25, 2026LeadershipThe Board of Directors of Cencora, Inc. appointed Robert E. Sanchez to serve on the Board, effective October 1, 2026. Filing
  5. Aug 14, 2026LeadershipFollowing the conclusion of the quarterly meeting of the Board of Directors of Cencora, Inc., Lorence H. Kim, M.D., informed the Company of his intent to resign from the Board effective immediately. Filing
  6. Aug 12, 2026AnnouncementShared information with investors. Filing
  7. Aug 5, 2026AgreementCencora, Inc. and its subsidiary Innomar Strategies Inc. entered into an Amended and Restated Credit Agreement to further amend and restate the Amended and Restated Credit Agreement, dated as of June 4, 2025 and as amended on January 12, 2026, among the Company, the borrowing subsidiaries party… Filing
  8. Aug 5, 2026ResultsReleased financial results. Filing
  9. Jun 15, 2026LeadershipCencora, Inc. announced that Silvana Battaglia will retire as Executive Vice President and Chief Human Resources Officer of the Company effective July 12, 2026. Filing
  10. May 29, 2026LeadershipCencora, Inc. announced that Eva C. Boratto has been appointed Executive Vice President and Chief Financial Officer of the Company, effective June 29, 2026. Filing
  11. May 6, 2026ResultsReleased financial results. Filing
  12. Mar 23, 2026AnnouncementShared information with investors. Filing
  13. Mar 17, 2026LeadershipCencora, Inc. announced that James F. Cleary will retire as Executive Vice President and Chief Financial Officer of the Company effective June 30, 2026. Filing
  14. Mar 6, 2026VoteReported shareholder vote results. Filing
  15. Feb 18, 2026AnnouncementThe Company entered into a definitive agreement to merge MWI with Covetrus. Filing
  16. Feb 13, 2026AgreementCencora, Inc. completed the sale of $3.0 billion of the Company’s Senior Notes as follows: $500 million of the Company’s 3.950% Senior Notes due 2029, $500 million of the Company’s 4.250% Senior Notes due 2030, $500 million of the Company’s 4.600% Senior Notes due 2033, $1 billion of the Company’s… Filing
  17. Feb 11, 2026AnnouncementThe Company entered into an Underwriting Agreement, by and among the Company, Citigroup Global Markets Inc., J.P. Morgan Securities LLC, BofA Securities, Inc. and Wells Fargo Securities, LLC on behalf of themselves and as representatives of the several underwriters named therein. Filing
  18. Feb 10, 2026AnnouncementCencora, Inc. is filing this Current Report on Form 8-K (this “Form 8-K”) to reflect a revision to the presentation of its financial information as set forth in its Annual Report on Form 10-K for the fiscal year ended September 30, 2025, as filed with the Securities and Exchange Commission on… Filing
  19. Feb 4, 2026ResultsReleased financial results. Filing
  20. Jan 22, 2026LeadershipThe Board of Directors of Cencora, Inc. appointed Ellen G. Cooper to serve on the Board, effective immediately. Filing
  21. Jan 16, 2026AgreementCencora, Inc. entered into an Incremental Facility and Amendment Agreement to that certain Amended and Restated Credit Agreement (as amended by the Amendment, the “Revolving Credit Agreement”), dated as of June 4, 2025, among the Company, the borrowing subsidiaries party thereto, the lenders party… Filing
  22. Dec 15, 2025AnnouncementThe Company entered into an agreement to acquire the majority of the outstanding equity interests that it does not currently own in OneOncology from TPG and other shareholders for approximately $3.6 billion and retire its existing corporate debt of $1.3 billion, for a total cash consideration of… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Cencora financials

Famous investors that hold COR

6 of the 50 well-known investors we track reported holding COR in their latest 13F filing. The largest position is Ken Griffin's, worth $405M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 20261.35M$405M0.2%-1%
Israel Englander · Millennium ManagementQ3 2026794,117$238M0.2%-16%
Steve Cohen · Point72 Asset ManagementQ3 2026659,168$198M0.3%+9%
Jim Simons · Renaissance TechnologiesQ3 2026230,180$69.1M0.1%+875%
Ray Dalio · Bridgewater AssociatesQ3 202650,395$15.1M0.1%+48%
Ken Fisher · Fisher Asset ManagementQ3 20264,094$1.2M0.0%+10%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Cencora, Inc. (COR) stock

Who owns the most COR stock?

The largest reported owner of Cencora, Inc. (COR) is BlackRock, Inc., with 9.4% of the company. In total, 1,339 funds and institutions reported holding COR at the end of Q2 2026, together about 94% of the shares. See the largest owners.

Are COR insiders buying or selling?

In the last 12 months, COR insiders reported 3 open-market purchases worth $2.3M and 13 sales worth $15.4M. The latest trade was on Nov 2, 2026. See every trade.

What is the short interest in COR?

As of Oct 30, 2026, 3.16M COR shares were sold short, 1.7% of the shares outstanding, down 19.7% from the report before. At the average daily volume of 1.21M shares, buying them all back would take about 2.6 trading days (days to cover). See the history.

Have members of Congress traded COR?

Yes. 4 members of Congress reported 4 purchases and 4 sales of COR since Nov 17, 2024. The latest was reported on Jul 21, 2026. See the trades.

Which famous investors hold COR?

6 of the 50 well-known investors we track reported COR in their latest 13F filing, including Ken Griffin, Israel Englander, Steve Cohen. The largest position is worth $405M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.